Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease

Neurochemistry International

Volumn 60, Issue 3, 2012, Pages 257-266

  Bi, Bing Tian ^a   Lin, Huan Bing ^b   Cheng, Yu Fang ^a   Zhou, Heng ^a   Lin, Ting ^a   Zhang, Ming Zi ^a   Li, Tie Jun ^c   Xu, Jiang Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Food and Drug Administration Center for Evaluation and Certification   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid protein; Alzheimer's disease; APP PS1 transgenic mice; C reactive protein; Cytotoxicity; PC12 cells

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; LACTATE DEHYDROGENASE; MESSENGER RNA; PRESENILIN 1; PRESENILIN 2; SERUM AMYLOID P; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL CELL; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAR WESTERN BLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BLOTTING, WESTERN; C-REACTIVE PROTEIN; COLORING AGENTS; COMPLEMENT C1; ENZYME-LINKED IMMUNOSORBENT ASSAY; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PC12 CELLS; PRESENILIN-1; PRESENILIN-2; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS; RATTUS;

EID: 84862804934     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.12.007     Document Type: Article

References (64)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421 (Pubitemid 30349107)
2. I. Blasko, M. Stampfer-Kountchev, P. Robatscher, R. Veerhuis, P. Eikelenboom, and B. Grubeck-Loebenstein How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes Aging Cell 3 2004 169 176 (Pubitemid 40253499)
3. M. Botto, P.N. Hawkins, M.C. Bickerstaff, J. Herbert, A.E. Bygrave, A. McBride, W.L. Hutchinson, G.A. Tennent, M.J. Walport, and M.B. Pepys Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene Nat. Med. 3 1997 855 859 (Pubitemid 27353444)
4. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
5. H. Braak, and E. Braak Evolution of neuronal changes in the course of Alzheimer's disease J. Neural Transm. Suppl. 53 1998 127 140 (Pubitemid 28361774)
6. V. Brade, G.D. Lee, A. Nicholson, H.S. Shin, and M.M. Mayer The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway J. Immunol. 111 1973 1389 1400
7. D.R. Claus, A.P. Osmand, and H. Gewurz Radioimmunoassay of human C-reactive protein and levels in normal sera J. Lab. Clin. Med. 87 1976 120 128
8. C.M. Colley, A. Fleck, A.W. Goode, B.R. Muller, and M.A. Myers Early time course of the acute phase protein response in man J. Clin. Pathol. 36 1983 203 207 (Pubitemid 13190318)
9. N.R. Cooper, B.M. Bradt, S. O'Barr, and J.X. Yu Focal inflammation in the brain: role in Alzheimer's disease Immunol. Res. 21 2000 159 165
10. C. Czech, G. Tremp, and L. Pradier Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms Prog. Neurobiol. 60 2000 363 384
11. T. Duong, M. Nikolaeva, and P.J. Acton C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease Brain Res. 749 1997 152 156 (Pubitemid 27096469)
12. T. Duong, P.J. Acton, and R.A. Johnson The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions Brain Res. 813 1998 303 312 (Pubitemid 29009646)
13. S.S. Durairajan, Q. Yuan, L. Xie, W.S. Chan, W.F. Kum, I. Koo, C. Liu, Y. Song, J.D. Huang, W.L. Klein, and M. Li Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty Neurochem. Int. 52 2008 741 750
14. R. Fan, and A.J. Tenner Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures Exp. Neurol. 185 2004 241 253 (Pubitemid 38084850)
15. X. Fernandez-Busquets, J. Ponce, R. Bravo, M. Arimon, T. Martianez, A. Gella, J. Cladera, and N. Durany Modulation of amyloid beta peptide(1-42) cytotoxicity and aggregation in vitro by glucose and chondroitin sulfate Curr. Alzheimer Res. 7 2010 428 438
16. F. George, and A.T. John In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride Toxicol. Lett. 160 2006 171 177
17. T.E. Golde, and S.G. Younkin Presenilins as therapeutic targets for the treatment of Alzheimer's disease Trends Mol. Med. 7 2001 264 269 (Pubitemid 32545523)
18. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. USA 73 1976 2424 2428
19. F.G. Hage, S. Oparil, D. Xing, Y.F. Chen, M.A. McCrory, and A.J. Szalai C-reactive protein-mediated vascular injury requires complement Arterioscler. Thromb. Vasc. Biol. 30 2010 1189 1195
20. T. Hartmann, S.C. Bieger, B. Bruhl, P.J. Tienari, N. Ida, D. Allsop, G.W. Roberts, C.L. Masters, C.G. Dotti, K. Unsicker, and K. Beyreuther Distinct sites of intracellular production for Alzheimer's disease Abeta 40/42 amyloid peptides Nat. Med. 3 1997 1016 1020 (Pubitemid 27391957)
21. F. Haverkate C-reactive protein as cardiovascular risk factor. A discovery by ECAT Clin. Chem. Lab. Med. 38 2000 1055
22. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 4 1998 97 100 (Pubitemid 28133087)
23. N. Iwamoto, E. Nishiyama, J. Ohwada, and H. Arai Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections Neurosci. Lett. 177 1994 23 26 (Pubitemid 24269420)
24. H.X. Jiang, J.N. Siegel, and H. Gewurz Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q J. Immunol. 146 1991 2324 2330
25. H. Jiang, D. Burdick, C.G. Glabe, C.W. Cotman, and A.J. Tenner Beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain J. Immunol. 152 1994 5050 5059
26. J.K. Krady, A. Basu, C.M. Allen, Y. Xu, K.F. LaNoue, T. Gardner, and S.W. Levison Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in arodent model of diabetic retinopathym J. Diabetes 54 2005 1559 1565 (Pubitemid 40586690)
27. B.A. Kravitz, M.M. Corrada, and C.H. Kawas Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old Alzheimers Dement. 5 2009 318 323
28. F. Licastro, M.C. Morini, E. Polazzi, and L.J. Davis Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response J. Neuroimmunol. 57 1995 71 75
29. H.B. Lin, X.M. Yang, T.J. Li, Y.F. Cheng, H.T. Zhang, and J.P. Xu Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease Psychopharmacology 204 2009 705 714
30. A. Mancinella, M. Mancinella, G. Carpinteri, A. Bellomo, C. Fossati, V. Gianturco, A. Iori, E. Ettorre, G. Troisi, and V. Marigliano Is there a relationship between high C-reactive protein (CRP) levels and dementia? Arch. Gerontol. Geriatr. 49 2009 185 194
31. M. Marcinkiewicz, and N.G. Seidah Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain J. Neurochem. 75 2000 2133 2143
32. P.L. McGeer, E.G. McGeer, and K. Yasojima Alzheimer disease and neuroinflammation J. Neural Transm. Suppl. 59 2000 53 57 (Pubitemid 30479406)
33. E.G. McGeer, K. Yasojima, C. Schwab, and P.L. McGeer The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases Neurobiol. Aging 22 2001 843 848 (Pubitemid 34066551)
34. E. McGowan, S. Sanders, T. Iwatsubo, A. Takeuchi, T. Saido, C. Zehr, X. Yu, S. Uljon, R. Wang, D. Mann, D. Dickson, and K. Duff Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes Neurobiol. Dis. 6 1999 231 244 (Pubitemid 29470035)
35. T. Meri, R. Murgia, P. Stefanel, S. Meri, and M. Cinco Regulation of complement activation at the C3-level by serum resistant leptospires Microb. Pathog. 39 2005 139 147 (Pubitemid 41413261)
36. F. Misiti, M.E. Clementi, and B. Giardina Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function Neurochem. Int. 56 2010 597 602
37. J.N. Octave, R. Essalmani, B. Tasiaux, J. Menager, C. Czech, and L. Mercken The role of presenilin-1 in the gamma-secretase cleavage of the amyloid precursor protein of Alzheimer's disease J. Biol. Chem. 275 2000 1525 1528 (Pubitemid 30060763)
38. E.J. Okello, G.J. McDougall, S. Kumar, and C.J. Seal In vitro protective effects of colon-available extract of Camellia sinensis (tea) against hydrogen peroxide and beta-amyloid (Abeta(1-42)) induced cytotoxicity in differentiated PC12 cells Phytomedicine 18 2010 691 696
39. S.Y. Park, H.S. Kim, E.K. Cho, B.Y. Kwon, S. Phark, K.W. Hwang, and D. Sul Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation Food Chem. Toxicol. 46 2008 2881 2887
40. Y.H. Park, I.H. Son, B. Kim, Y.S. Lyu, H.I. Moon, and H.W. Kang Poria cocos water extract (PCW) protects PC12 neuronal cells from beta-amyloid-induced cell death through antioxidant and antiapoptotic functions Pharmazie 64 2009 760 764
41. M.B. Pepys, R.F. Dyck, F.C. de Beer, M. Skinner, and A.S. Cohen Binding of serum amyloid P-component (SAP) by amyloid fibrils Clin. Exp. Immunol. 38 1979 284 293 (Pubitemid 10196196)
42. M.B. Pepys, G.M. Hirschfield, G.A. Tennent, J.R. Gallimore, M.C. Kahan, V. Bellotti, P.N. Hawkins, R.M. Myers, M.D. Smith, A. Polara, A.J. Cobb, S.V. Ley, J.A. Aquilina, C.V. Robinson, I. Sharif, G.A. Gray, C.A. Sabin, M.C. Jenvey, S.E. Kolstoe, D. Thompson, and S.P. Wood Targeting C-reactive protein for the treatment of cardiovascular disease Nature 440 2006 1217 1221
43. R.O. Roberts, Y.E. Geda, D.S. Knopman, B.F. Boeve, T.J. Christianson, V.S. Pankratz, I.J. Kullo, E.G. Tangalos, R.J. Ivnik, and R.C. Petersen Association of C-reactive protein with mild cognitive impairment Alzheimers Dement. 5 2009 398 405
44. J. Rogers, S. Webster, L.F. Lue, L. Brachova, W.H. Civin, M. Emmerling, B. Shivers, D. Walker, and P. McGeer Inflammation and Alzheimer's disease pathogenesis Neurobiol. Aging 17 1996 681 686 (Pubitemid 26348868)
45. A. Sahu, and J.D. Lambris Structure and biology of complement protein C3, a connecting link between innate and acquired immunity Immunol. Rev. 180 2001 35 48 (Pubitemid 32472850)
46. A. Salminen, J. Ojala, A. Kauppinen, K. Kaarniranta, and T. Suuronen Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors Prog. Neurobiol. 87 2009 181 194
47. A. Schuitemaker, M.G. Dik, R. Veerhuis, P. Scheltens, N.S. Schoonenboom, C.E. Hack, M.A. Blankenstein, and C. Jonker Inflammatory markers in AD and MCI patients with different biomarker profiles Neurobiol. Aging 30 2009 1885 1889
48. D.J. Selkoe Amyloid beta-protein and the genetics of Alzheimer's disease J. Biol. Chem. 271 1996 18295 18298 (Pubitemid 26322675)
49. 2+ dyshomeostasis that is blocked by EGb761 Neurochem. Int. 56 2010 893 905
50. P.D. Sloane, S. Zimmerman, C. Suchindran, P. Reed, L. Wang, M. Boustani, and S. Sudha The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances Annu. Rev. Public Health 23 2002 213 231 (Pubitemid 34508073)
51. Z. Song, L. Cai, L. Guo, Y. Tsukamoto, C. Yutani, and X.A. Li Accumulation and expression of serum amyloid P component in human atherosclerotic lesions Atherosclerosis 211 2010 90 95
52. E. Storey, and R. Cappai The amyloid precursor protein of Alzheimer's disease and the Abeta peptide Neuropathol. Appl. Neurobiol. 25 1999 81 97 (Pubitemid 29221758)
53. R.C. Strunk, and P.C. Giclas Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5 J. Immunol. 124 1980 520 526 (Pubitemid 10147648)
54. Y.J. Sung, C.L. Cheng, C.S. Chen, H.B. Huang, F.L. Huang, P.C. Wu, M.S. Shiao, and H.J. Tsay Distinct mechanisms account for beta-amyloid toxicity in PC12 and differentiated PC12 neuronal cells J. Biomed. Sci. 10 2003 379 388
55. T. Town Inflammation, immunity, and Alzheimer's disease CNS. Neurol. Disord. Drug Targets 9 2010 129 131
56. R. Vassar The beta-secretase, BACE: a prime drug target for Alzheimer's disease J. Mol. Neurosci. 17 2001 157 170 (Pubitemid 33063520)
57. R. Vassar Beta-secretase (BACE) as a drug target for Alzheimer's disease Adv. Drug Deliv. Rev. 54 2002 1589 1602 (Pubitemid 35346833)
58. B. Vellas Tarenflurbil for Alzheimer's disease: a "shot on goal" that missed Lancet Neurol. 9 2010 235 237
59. S. Verma, M.A. Kuliszewski, S.H. Li, P.E. Szmitko, L. Zucco, C.H. Wang, M.V. Badiwala, D.A. Mickle, R.D. Weisel, P.W. Fedak, D.J. Stewart, and M.J. Kutryk C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease Circulation 109 2004 2058 2067 (Pubitemid 38620212)
60. M.L. Vetter, H. Gewurz, and L.L. Baum The effects of C-reactive protein on human cell-mediated cytotoxicity J. Leukoc. Biol. 39 1986 13 25 (Pubitemid 16212681)
61. T.C. Vukovich, S. Mustafa, H. Rumpold, and O. Wagner Evaluation of a turbidimetric Denka Seiken C-reactive protein assay for cardiovascular risk estimation and conventional inflammation diagnosis Clin. Chem. 49 2003 511 512 (Pubitemid 36250219)
62. K. Yasojima, C. Schwab, E.G. McGeer, and P.L. McGeer Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease Brain Res. 887 2000 80 89 (Pubitemid 32008026)
63. A. Zaciragic, O. Lepara, A. Valjevac, S. Arslanagic, A. Fajkic, A. Hadzovic-Dzuvo, N. Avdagic, A. Alajbegovic, E. Mehmedika-Suljic, and G. Coric Elevated serum C-reactive protein concentration in Bosnian patients with probable Alzheimer's disease J. Alzheimers Dis. 12 2007 151 156 (Pubitemid 47509372)
64. E. Zotova, J.A. Nicoll, R. Kalaria, C. Holmes, and D. Boche Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy Alzheimers Res. Ther. 2 2010 1